InspireMD, Inc.
NSPR
NASDAQ·Healthcare·Medical - Devices·Mkt cap $40.0M
$0.85
▲ +1.26%
P/E
-5.14
Mkt Cap
$40.0M
52-Wk Range
$0.63–$2.57
52-Week Range
$0.63 - $2.57
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 64.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Average volatility.
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Stable
-3.0% over 3m
Quality
Thin
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying NSPR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 10, 2026
AUG 14, 2026
Reported EPS of -$0.17 vs -$0.20 consensus (+15.0% surprise). Revenue of $1.8M vs $1.4M expected (+28.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+15.0%
Revenue trend · last 2Q
—
-0%
Q1 26
Q2 26
$3.4M
$1.8M
Margins · last 2Q
Gross
-43.7%
Profit
-808.8%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Piper Sandler · $3.00 · May 5, 2026
vs Industry
How NSPR stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.